Five most recent developments in the Allergan-Valeant saga

The ongoing takeover battle between Valeant and Allergan has shown no sign of closure, as further speculation of bids continue to flood the industry news wires.In April, William A. Ackman and Valeant first announced they would try to acquire Allergan; however, a series of events have since unfolded. From Allergan’s lawsuit against Valeant and Pershing Square, to a potential deal with Salix Pharmaceuticals, has provided the latest coverage of this ongoing story.

Full Story →